Welcome to our dedicated page for Amesite news (Ticker: AMST), a resource for investors and traders seeking the latest updates and insights on Amesite stock.
Amesite Inc. (NASDAQ: AMST) is an AI-driven technology company whose recent news flow centers on its NurseMagic™ platform for healthcare and post-acute care. The Amesite (AMST) news page on Stock Titan aggregates company-issued press releases and related coverage so readers can follow how the business is developing its AI-powered solutions for nurses, caregivers, and healthcare organizations.
Recent announcements highlight the evolution of NurseMagic™ from an AI assistant for individual clinicians into an enterprise platform and, more recently, an AI-native electronic medical record (EMR) for post-acute care. News items describe new tiers such as Teams Plus+ and NurseMagic™ Enterprise, census-based pricing models, EMR integration, automated interdisciplinary team reporting, and tools for government form automation and regulatory documentation.
Investors and observers can use this page to review updates on revenue growth associated with NurseMagic™, expansion into non-clinical caregiver segments, multilingual charting capabilities, and HIPAA-related milestones for both enterprise and individual users. The company’s releases also discuss customer adoption across home health, hospice, skilled nursing, senior living, and home care providers, as well as usage across all 50 U.S. states and multiple countries.
In addition to product and market developments, Amesite’s news includes commentary on broader conditions affecting its business, such as trade policy impacts on software providers and the company’s positioning with a U.S.-based, cloud-native infrastructure. For a concise view of these developments, the AMST news page offers a centralized feed that can be revisited regularly to track changes in Amesite’s product roadmap, market focus, and reported performance drivers.
Amesite Inc. has successfully closed its initial public offering (IPO) raising $15.0 million by offering 3,000,000 shares of common stock at $5.00 per share. The IPO, which commenced trading on the Nasdaq under the ticker AMST on September 25, 2020, includes an option for underwriters to purchase up to an additional 450,000 shares to cover over-allotments. Laidlaw & Company (UK) Ltd. served as the sole book-running manager for this offering. The opened shares are expected to enhance Amesite's financial capabilities.